Related Experiment Video
Updated: May 8, 2026

Organotypic Retinal Explant Cultures from Macaque Monkey
Published on: August 24, 2022
Programmed necrosis, not apoptosis, is a key mediator of cell loss and DAMP-mediated inflammation in dsRNA-induced
Y Murakami1, H Matsumoto2, M Roh2
11] Department of Ophthalmology, Retina Service, Angiogenesis Laboratory, Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, MA, USA [2] Department of Ophthalmology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Abstract:
There is no known treatment for the dry form of an age-related macular degeneration (AMD). Cell death and inflammation are important biological processes thought to have central role in AMD. Here we show that receptor-interacting protein (RIP) kinase mediates necrosis and enhances inflammation in a mouse model of retinal degeneration induced by dsRNA, a component of drusen in AMD. In contrast to photoreceptor-induced apoptosis, subretinal injection of the dsRNA analog poly(I : C) caused necrosis of the retinal pigment epithelium (RPE), as well as macrophage infiltration into the outer retinas. In Rip3(-/-) mice, both necrosis and inflammation were prevented, providing substantial protection against poly(I : C)-induced retinal degeneration. Moreover, after poly(I : C) injection, Rip3(-/-) mice displayed decreased levels of pro-inflammatory cytokines (such as TNF-α and IL-6) in the retina, and attenuated intravitreal release of high-mobility group box-1 (HMGB1), a major damage-associated molecular pattern (DAMP). In vitro, poly(I : C)-induced necrosis were inhibited in Rip3-deficient RPE cells, which in turn suppressed HMGB1 release and dampened TNF-α and IL-6 induction evoked by necrotic supernatants. On the other hand, Rip3 deficiency did not modulate directly TNF-α and IL-6 production after poly(I : C) stimulation in RPE cells or macrophages. Therefore, programmed necrosis is crucial in dsRNA-induced retinal degeneration and may promote inflammation by regulating the release of intracellular DAMPs, suggesting novel therapeutic targets for diseases such as AMD.
Insights
Receptor-interacting protein (RIP) kinase mediates necrosis and inflammation in a mouse model of age-related macular degeneration (AMD). RIP3 deficiency prevented retinal degeneration, suggesting it as a therapeutic target for AMD.
Area of Science:
- Ophthalmology
- Immunology
- Cell Biology
Background:
- Age-related macular degeneration (AMD) lacks effective treatments, with cell death and inflammation implicated in its progression.
- Drusen, a hallmark of AMD, contain double-stranded RNA (dsRNA).
Purpose of the Study:
- To investigate the role of receptor-interacting protein (RIP) kinase in dsRNA-induced retinal degeneration and inflammation.
- To explore RIP3 as a potential therapeutic target for dry AMD.
Main Methods:
- A mouse model of retinal degeneration induced by poly(I:C) (a dsRNA analog).
- Assessment of retinal pigment epithelium (RPE) necrosis, macrophage infiltration, and pro-inflammatory cytokine levels (TNF-α, IL-6).
- Evaluation of high-mobility group box-1 (HMGB1) release in Rip3-deficient mice and cells.
Main Results:
- Poly(I:C) induced RPE necrosis and inflammation in wild-type mice, but this was prevented in Rip3(-/-) mice.
- Rip3 deficiency reduced pro-inflammatory cytokine levels and HMGB1 release in the retina.
- In vitro studies confirmed that Rip3 deficiency inhibited dsRNA-induced RPE necrosis and subsequent inflammatory mediator release.
Conclusions:
- Programmed necrosis mediated by RIP3 is critical in dsRNA-induced retinal degeneration.
- RIP3-dependent necrosis promotes inflammation by regulating damage-associated molecular pattern (DAMP) release.
- Targeting RIP kinase offers a potential therapeutic strategy for AMD.
Related Concept Videos
Necrosis
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become anucleated and die, but their...
Overview of Cell Death
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the 20th century...
Cellular Injury IlI: Cellular Death
Apoptosis
Cellular Injury IV: Necrosis
Cellular Injury V: Apoptosis and Autophagy